Sterigenics International to Build EO Sterilization Complex in Costa Rica
Oak Brook, IL - September 30, 2010: Sterigenics International, the global leader in contract sterilization and ionization services to the medical device, pharmaceutical, food safety and advanced applications industries is proud to announce its plans to begin construction of a state-of-the-art, Ethylene Oxide sterilization facility near San José, Costa Rica.
"Costa Rica is an attractive manufacturing and distribution base for medical device manufacturers. This project is a great opportunity to execute on our strategy of expanding our global network of facilities and technologies to service our customer base. We are very appreciative of the support from the Costa Rican government and the Costa Rican Investment Promotional Agency (CINDE). We believe that as our customer base continues to grow in Costa Rica, additional investments will follow," said David E. Meyer, President and CEO of Sterigenics.
"Our customers are pleased that we have selected Costa Rica for our next expansion project. Our commitment to meeting the requirements of current and prospective customers is always a priority. Having a new distribution channel and more capacity in this strategic location will have a significant and positive impact on our company. We build or add capacity where the market needs our services and we will continue to analyze other expansion opportunities," said Patrick J. Hughes, Vice President of Sales and Marketing for Sterigenics in the Americas.
"To be able to rely on another sterilization technology is imperative for the medical device industry and further develops this sector, reaffirming Costa Rica as a destination where companies are able to find an attractive location to operate," said Gabriela Llobet, Director General of CINDE in support of Sterigenics new facility.
"The government is committed to continual improvement of the conditions so that Foreign Direct Investment can grow organically in our country. We recognize that companies like Sterigenics contribute significantly to Costa Rica´s development, which is why we are immensely pleased with the establishment of this new service provider in the medical device industry which has undergone remarkable growth becoming the third largest goods exporter in our country, registering annually an average US$1,028 million," states Anabel González, Minister of Foreign Trade for Costa Rica.
Sterigenics will invest approximately $7 million to complete the first phase of the project in 2011, and expects that the new facility will be fully operational by January 2012.
About Sterigenics International
Sterigenics International Inc. is a portfolio company of Silverfleet Capital and PPM America Capital Partners.
Headquartered in the Chicago suburb of Oak Brook, IL, Sterigenics International is the only company in the world to offer technology in all leading sterilization modalities, including: gamma, ethylene oxide, electron beam and X-ray. The company has more than 1,300 employees and operates 38 service centers in North America, Europe and Asia.
